The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.
The DCP Community Oncology and Prevention Trials Research Group administers this program.
On this page
About NCORP
The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.
Grantee Details
No matching Grants were found.
Clinical Trials
| Title Sort descending | Intervention | Sponsor | Status |
|---|---|---|---|
| S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer | acupuncture therapy, sham acupuncture | SWOG Cancer Research Network | Completed |
| S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy | duloxetine hydrochloride, placebo | SWOG Cancer Research Network | Completed |
| S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction | gastrointestinal complications management/prevention, quality-of-life assessment, therapeutic conventional surgery | SWOG Cancer Research Network | Completed |
| S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) | Preventive Intervention, Quality-of-Life Assessment, Questionnaire Administration | SWOG Cancer Research Network | Completed |
| S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer | Quality-of-Life Assessment, Questionnaire Administration | SWOG Cancer Research Network | Completed |
| S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer | Carvedilol, Laboratory Biomarker Analysis, Patient Observation | SWOG Cancer Research Network | Recruiting |
| S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer | Anxiety Questionnaire Administration, Quality-of-Life Assessment, Serum Tumor Marker directed disease monitoring, Usual care disease monitoring | SWOG Cancer Research Network | Recruiting |
| Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia | Best Practice, Laboratory Biomarker Analysis, Supportive Care | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
| Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer | Standard radiation therapy, intensity-modulated radiation therapy | Radiation Therapy Oncology Group | Completed |
| Stepped-Care Telehealth for Distress in Cancer Survivors | Enhanced Usual Care Control, Moderate Anxiety/depression: Low Intensity Stepped care, Severe Anxiety/depression: High Intensity Stepped Care | Wake Forest University Health Sciences | Completed |